Academic Journal
Προβολή σε EDS

Pulmonary hypertension in the elderly, part 2: treatment.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Pulmonary hypertension in the elderly, part 2: treatment.
Συγγραφείς: Bone-Larson CL (AUTHOR), Chan KM (AUTHOR)
Πηγή: Journal of Respiratory Diseases. Dec2008, Vol. 29 Issue 12, p468-474. 7p.
Περίληψη: The treatment of pulmonary arterial hypertension (PAH) is directed at the underlying cause, such as diastolic heart failure or chronic thromboembolic disease. Patients with idiopathic PAH or PAH associated with connective-tissue disease who have World Health Organization (WHO) functional class II or III PAH should receive a trial of oral bosentan, ambrisentan, and/or sildenafil; inhaled iloprost is an alternative or an additive agent. If patients fail to respond to these interventions or if they have WHO functional class IV PAH, consider subcutaneous or intravenous treprostinil or epoprostenol. The use of these latter agents is much more complicated and may be difficult to initiate in elderly patients. [ABSTRACT FROM AUTHOR]
Βάση Δεδομένων: Supplemental Index
FullText Text:
  Availability: 0
Header DbId: edo
DbLabel: Supplemental Index
An: 105610360
RelevancyScore: 833
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 833.215148925781
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pulmonary hypertension in the elderly, part 2: treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Bone-Larson+CL%22">Bone-Larson CL</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chan+KM%22">Chan KM</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Journal+of+Respiratory+Diseases%22">Journal of Respiratory Diseases</searchLink>. Dec2008, Vol. 29 Issue 12, p468-474. 7p.
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The treatment of pulmonary arterial hypertension (PAH) is directed at the underlying cause, such as diastolic heart failure or chronic thromboembolic disease. Patients with idiopathic PAH or PAH associated with connective-tissue disease who have World Health Organization (WHO) functional class II or III PAH should receive a trial of oral bosentan, ambrisentan, and/or sildenafil; inhaled iloprost is an alternative or an additive agent. If patients fail to respond to these interventions or if they have WHO functional class IV PAH, consider subcutaneous or intravenous treprostinil or epoprostenol. The use of these latter agents is much more complicated and may be difficult to initiate in elderly patients. [ABSTRACT FROM AUTHOR]
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edo&AN=105610360
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 468
    Titles:
      – TitleFull: Pulmonary hypertension in the elderly, part 2: treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bone-Larson CL
      – PersonEntity:
          Name:
            NameFull: Chan KM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2008
              Type: published
              Y: 2008
          Identifiers:
            – Type: issn-print
              Value: 0194259X
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Journal of Respiratory Diseases
              Type: main
ResultId 1